Federal Register - August 18, 2021

Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.

Source: Federal Register

Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Rules and Regulations subject to reporting under this section for the significant new uses described in paragraph a2 of this section.
2 The significant new uses are:
i Hazard communication.
Requirements as specified in 721.72a through f, g1, g2i through iii, g3i and ii, and g5. For purposes of 721.72e, the concentration is set at 1.0%. For purposes of 721.72g1, this substance may cause: Skin irritation; respiratory complications;
central nervous system effects; internal organ effects; reproductive effects;
developmental effects; eye irritation.
Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA
Hazard Communication Standard may be used.
ii Industrial, commercial, and consumer activities. Requirements as specified in 721.80k and q. It is a significant new use to manufacture or process the substance without including the engineering controls/processes described in the premanufacture notice.
iii Release to water. Requirements as specified in 721.90a4, b4, and c4 where N=14.
b Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph b.
1 Recordkeeping. Recordkeeping requirements as specified in 721.125a through c, f through i, and k are applicable to manufacturers and processors of this substance.
2 Limitation or revocation of certain notification requirements. The provisions of 721.185 apply to this section.
3 Determining whether a specific use is subject to this section. The provisions of 721.1725b1 apply to paragraph a2ii of this section.

jbell on DSKJLSW7X2PROD with RULES

721.11439 Halogenated benzoic acid, ethyl ester generic P19105.

a Chemical substance and significant new uses subject to reporting.
1 The chemical substance identified generically as halogenated benzoic acid, ethyl ester PMN P19105 is subject to reporting under this section for the significant new uses described in paragraph a2 of this section.
2 The significant new uses are:
i Hazard communication.
Requirements as specified in 721.72a through f, g1, g2i through iii, g3i and ii, and g5. For purposes of 721.72e, the concentration is set at 1.0%. For purposes of 721.72g1, this substance may cause: Skin irritation; respiratory complications;
central nervous system effects; internal organ effects; reproductive effects;

VerDate Sep<11>2014

16:01 Aug 17, 2021

Jkt 253001

developmental effects; eye irritation.
Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA
Hazard Communication Standard may be used.
ii Industrial, commercial, and consumer activities. Requirements as specified in 721.80k and q. It is a significant new use to manufacture or process the substance without including the engineering controls/processes described in the premanufacture notice.
iii Release to water. Requirements as specified in 721.90a4, b4, and c4 where N=14.
b Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph b.
1 Recordkeeping. Recordkeeping requirements as specified in 721.125a through c, f through i, and k are applicable to manufacturers and processors of this substance.
2 Limitation or revocation of certain notification requirements. The provisions of 721.185 apply to this section.
3 Determining whether a specific use is subject to this section. The provisions of 721.1725b1 apply to paragraph a2ii of this section.
721.11440 Halogenated alkylbenzoic acid, ethyl ester generic P19106.

a Chemical substance and significant new uses subject to reporting.
1 The chemical substance identified generically as halogenated alkylbenzoic acid, ethyl ester PMN P19106 is subject to reporting under this section for the significant new uses described in paragraph a2 of this section.
2 The significant new uses are:
i Hazard communication.
Requirements as specified in 721.72a through f, g1, g2i, ii, and iii, g3i and ii, and g5. For purposes of 721.72e, the concentration is set at 1.0%. For purposes of 721.72g1, this substance may cause: Skin irritation; respiratory complications;
central nervous system effects; internal organ effects; reproductive effects;
developmental effects; eye irritation.
Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA
Hazard Communication Standard may be used.
ii Industrial, commercial, and consumer activities. Requirements as specified in 721.80k and q. It is a significant new use to manufacture or process the substance without including the engineering controls/processes described in the premanufacture notice.

PO 00000

Frm 00053

Fmt 4700

Sfmt 4700

46155

iii Release to water. Requirements as specified in 721.90a4, b4, and c4 where N=14.
b Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph b.
1 Recordkeeping. Recordkeeping requirements as specified in 721.125a through c, f through i, and k are applicable to manufacturers and processors of this substance.
2 Limitation or revocation of certain notification requirements. The provisions of 721.185 apply to this section.
3 Determining whether a specific use is subject to this section. The provisions of 721.1725b1 apply to paragraph a2ii of this section.
721.11441 Halogenated alkylbenzoic acid, ethyl ester generic P19107.

a Chemical substance and significant new uses subject to reporting.
1 The chemical substance identified generically as halogenated alkylbenzoic acid, ethyl ester PMN P19107 is subject to reporting under this section for the significant new uses described in paragraph a2 of this section.
2 The significant new uses are:
i Hazard communication.
Requirements as specified in 721.72a through f, g1, g2i through iii, g3i and ii, and g5. For purposes of 721.72e, the concentration is set at 1.0%. For purposes of 721.72g1, this substance may cause: Skin irritation; respiratory complications;
central nervous system effects; internal organ effects; reproductive effects;
developmental effects; eye irritation.
Alternative hazard and warning statements that meet the criteria of the Globally Harmonized System and OSHA
Hazard Communication Standard may be used.
ii Industrial, commercial, and consumer activities. Requirements as specified in 721.80k and q. It is a significant new use to manufacture or process the substance without including the engineering controls/processes described in the premanufacture notice.
iii Release to water. Requirements as specified in 721.90a4, b4, and c4 where N=14.
b Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph b.
1 Recordkeeping. Recordkeeping requirements as specified in 721.125a through c, f through i, and k are applicable to manufacturers and processors of this substance.
2 Limitation or revocation of certain notification requirements. The
E:FRFM18AUR1.SGM

18AUR1

Riguardo a questa edizione

Federal Register - August 18, 2021

TitoloFederal Register

PaeseStati Uniti

Data18/08/2021

Conteggio pagine485

Numero di edizioni7798

Prima edizione14/03/1936

Ultima edizione18/06/2026

Scarica questa edizione

Altre edizioni

<<<Agosto 2021>>>
DLMMJVS
1234567
891011121314
15161718192021
22232425262728
293031